Crystallization (Comment) | Organism |
---|---|
wild-type and mutant A246F in complex with inhibitors | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
A246F | mutation introduces a large obstructive group into the pantetheinate channel, no detectable catalytic activity | Mycobacterium tuberculosis |
C112A | mutation of active site residue, no detectable activity | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-([[(2-hydroxyethyl)disulfanyl]carbonyl]oxy)octane | - |
Mycobacterium tuberculosis | |
11-[[(decyldisulfanyl)carbonyl]oxy]undecanoic acid | - |
Mycobacterium tuberculosis | |
11-[[(decyloxy)carbonyl]disulfanyl]undecanoic acid | - |
Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WNG3 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | P9WNG3 | - |
- |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0024 | - |
pH 7.4, 23°C | Mycobacterium tuberculosis | 11-[[(decyloxy)carbonyl]disulfanyl]undecanoic acid | |
0.0027 | - |
pH 7.4, 23°C | Mycobacterium tuberculosis | 11-[[(decyldisulfanyl)carbonyl]oxy]undecanoic acid | |
0.0038 | - |
pH 7.4, 23°C | Mycobacterium tuberculosis | 1-([[(2-hydroxyethyl)disulfanyl]carbonyl]oxy)octane |
General Information | Comment | Organism |
---|---|---|
metabolism | ordering or closing of the FabH on the substrate or inhibitor is required for efficient reaction with the active site cysteine. The acyl-CoA reactant, in principle, could synchronously bind to both arms of the exposed substrate binding site. Movement to the closed form, and reaction with Cys112, would follow. CoA product released from the mouth of the pantetheinate channel would then complete the first stage of the reaction | Mycobacterium tuberculosis |